The surgical site infection control market has seen considerable growth due to a variety of factors.
• The surgical site infection control market has expanded significantly in recent years. It is projected to grow from $4.74 billion in 2024 to $5 billion in 2025, at a CAGR of 5.5%.
This growth is driven by heightened awareness and emphasis on infection prevention, integration of infection control practices into healthcare systems, concerns about antibiotic resistance, a shift toward value-based care models, and stricter regulatory standards.
The surgical site infection control market is expected to maintain its strong growth trajectory in upcoming years.
• The surgical site infection control market is projected to grow significantly, reaching $6.1 billion by 2029 at a CAGR of 5.1%.
Growth is attributed to the rise in minimally invasive surgeries, an aging population, higher surgical volumes, the preference for single-use infection control products, and patient safety efforts. Trends include advanced sterilization technologies, single-use products, innovations in surgical techniques, and better PPE solutions.
The surgical site infection control market is likely to grow due to the increasing number of surgical procedures. Factors such as technological advancements, an aging population, and growing incidences of chronic diseases contribute to the increase in surgeries. Key aspects of surgical site infection control, such as sterilization, antibiotic prophylaxis, and aseptic techniques, play a crucial role in surgical proceedings to prevent infections, minimize complications, and enhance patient results. For example, the Government of British Columbia, a Canada-based administrative body, stated in May 2024 that 365,825 surgeries, both planned and unplanned, were completed. This figure includes 284,844 planned surgeries, a boost of 24,380 from 2019-20. The overall surgery figure, which covers both planned and emergency surgeries, is 14,939 higher than in the 2022-23 period. As a result, the escalating number of surgical procedures is fostering growth in the surgical site infection control market.
The surgical site infection control market covered in this report is segmented –
1) By Product: Surgical Scrubs, Hair Clippers, Surgical Drapes, Surgical Irrigation, Skin Preparation Solution, Medical Nonwovens, Surgical Gloves, Manual Reprocessor Solution, Disinfectants, Other Products
2) By Type Of Infection: Superficial Incisional Surgical Site Infection (SSI), Deep Incisional Surgical Site Infection (SSI), Organ Or Space Surgical Site Infection (SSI)
3) By Surgery Type: Cesarean Section, Gastric Bypass, Cataract Surgery, Dental Restoration, Other Surgery Types
4) By End-user: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Surgical Scrubs: Antimicrobial Surgical Scrubs, Non-Antimicrobial Surgical Scrubs
2) By Hair Clippers: Corded Hair Clippers, Cordless Hair Clippers
3) By Surgical Drapes: Sterile Surgical Drapes, Disposable Surgical Drapes, Reusable Surgical Drapes
4) By Surgical Irrigation: Sterile Irrigation Fluids, Antiseptic Irrigation Solutions, Non-Antiseptic Irrigation Solutions
5) By Skin Preparation Solution: Alcohol-Based Skin Preparations, Chlorhexidine-Based Skin Preparations, Povidone-Iodine-Based Skin Preparations
6) By Medical Nonwovens: Surgical Gowns, Surgical Masks, Sterile Sponges And Pads
7) By Surgical Gloves: Latex Surgical Gloves, Nitrile Surgical Gloves, Vinyl Surgical Gloves, Powdered Surgical Gloves, Powder-Free Surgical Gloves
8) By Manual Reprocessor Solution: Enzyme-Based Reprocessing Solutions, Chemical-Based Reprocessing Solutions
9) By Disinfectants: Alcohol-Based Disinfectants, Chlorine-Based Disinfectants, Hydrogen Peroxide-Based Disinfectants
10) By Other Products: Wound Care Products, Sterilization Equipment, Antiseptic Towelettes
Leading businesses in the surgical site infection control market are prioritizing the development of sophisticated products like surgical gowns featuring innovative fabric technology, in order to establish a competitive stance in the market. These specially designed surgical gowns offer improved protection and comfort, courtesy of advanced materials that provide superior barrier mechanisms, breathability, and durability. For instance, Invenio Medical Inc., a healthcare product manufacturer based in the United States, introduced their V90 series in March 2022. The series is meticulously designed to align with the stringent requirements of present-day healthcare facilities, while maintaining affordability. The V90 series encompasses numerous advanced features that enhance both performance and comfort. It is built to satisfy the high expectations of modern healthcare environments, where dependability and efficient performance are imperative. Invenio's new product unveiling signifies a meaningful step towards fulfilling the evolving needs of the healthcare sector with cutting-edge technology and pragmatic pricing models.
Major companies operating in the surgical site infection control market are:
• Johnson and Johnson
• Thermo Fisher Scientific Inc.
• 3M Company
• Kimberly-Clark Corporation
• Becton Dickinson and Company
• Stryker Corporation
• Owens & Minor Inc.
• B. Braun Melsungen AG
• Zimmer Biomet Holdings Inc
• Terumo Corporation
• Smith & Nephew plc
• Hartmann Group
• ConvaTec Inc.
• Ansell Limited
• Mölnlycke Health Care
• Halyard Health Inc.
• DeRoyal Industries Inc.
• Excelsior Medical LLC
• Xttrium Laboratories Inc.
• Precept Medical Products Inc.
• Cantel Medical Corp.
North America was the largest region in the surgical site infection control market in 2023. The regions covered in the surgical site infection control market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.